Hydration Pharmaceuticals Co. Ltd. (AU:HPC) has released an update.
Hydration Pharmaceuticals Co. Ltd. reported a decrease in revenues by 6% to $5.0 million and a 12% reduction in loss to $3.1 million for the first half of fiscal year 2024 compared to the previous year. The company also saw a decline in EBITDA loss by 34% to $2.4 million, with no dividends paid or declared during this period. Their net tangible assets per share also dropped from 0 cents in the previous period to negative 0.01 cents.
For further insights into AU:HPC stock, check out TipRanks’ Stock Analysis page.